Impact Analysis of Covid-19

The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Biopsy is a procedure of removing of a small amount of tissue for examination under a microscope. Imaging tests may suggest the diagnosis of sarcoma, but biopsy is performed to confirm the diagnosis and to find out the type of sarcoma. Several types of biopsies are used to diagnose sarcomas and most biopsies are needle biopsies, in which needle is used to access the suspicious tissue of sarcoma.

The global sarcoma biopsy market was valued at US$ 197.94  million in 2019 and is expected to exhibit a CAGR of 2.8% over the forecast period (2020-2027).

Fig1. Global Sarcoma Biopsy Market Share (%) Analysis, By Product Type, 2019

Sarcoma Biopsy  | Coherent Market Insights

Increasing prevalence of osteosarcoma is expected to drive growth of the global sarcoma biopsy market.

Osteosarcoma is the most common type of cancer affecting bones, and it mostly occurs in children and young adults. On the basis of cells, osteosarcoma is classified as high-, intermediate- and low-grade. For instance, according to the American Cancer Society, IN January 2020, around 800 to 900 new cases of osteosarcoma are diagnosed in the U.S. each year, with around 50% occurs in children and teenagers.

There are different type of biopsy procedures used to diagnose osteosarcoma such as needle biopsy and surgical biopsy.

Global Sarcoma Biopsy Market– Regional Analysis

North America accounted for the largest market share in the global sarcoma biopsy market, owing to rising healthcare expenditure in the U.S. For instance, according to the Committee for a Responsible Federal Budget, in 2017, the U.S. spent around US $ 3.5 trillion, or 18% of the total GDP, on health expenditures, which is more than twice the average among developed countries.

Furthermore, Asia Pacific is also expected to witness significant growth in the global sarcoma biopsy market, owing to increasing healthcare facilities. For instance, according to the India Brand Equity Foundation, in 2015 around 156,926 sub centers, and 196,312 hospitals are present in India.

Fig.2 Global Sarcoma Biopsy Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2027

Sarcoma Biopsy  | Coherent Market Insights

Global Sarcoma Biopsy Market- Competitive Landscape

Key players operating in the global sarcoma biopsy market include C. R. Bard, Inc., Becton, Dickinson and Company, Argon Medical Devices, InVivo Therapeutics Corporation, Cook Medical Incorporated, UROMED, and Sterylab

Sarcoma is a type of cancer, which occurs in connective tissues. Moreover, sarcoma is broadly classified into two types such as soft tissue sarcoma and bone sarcoma. Soft tissue sarcomas occur in tissues of blood vessels, nerves, tendons, muscles, fat, and lining of the joints. Soft tissue sarcomas are mostly found in legs, arms, abdomen, and chest. There are over 50 types of soft tissue sarcoma. Soft tissue sarcoma symptoms include lump growth, abdominal pain, blood in stools, and vomiting.

Market Dynamics

The global sarcoma biopsy market is expected to witness significant growth during the forecast period, owing to increasing prevalence of bone cancer. For instance, according to the American Society of Clinical Oncology, in 2018, around 3,450 new cases of bone cancer were registered and total 1,590 deaths occurred due to bone cancer in the U.S.

Bone cancer can be diagnosed using imaging techniques such as computerized tomography (CT), bone scan, magnetic resonance imaging (MRI), positron emission tomography (PET) scanning, and biopsy tests.

Key features of the study:

  • This report provides in-depth analysis of the global sarcoma biopsy market, market size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period: 2020-2027, considering 2019 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
  • It profiles key players in the global sarcoma biopsy market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key players covered as a part of this study include R. Bard, Inc., Becton, Dickinson and Company, Argon Medical Devices, InVivo Therapeutics Corporation, Cook Medical Incorporated, UROMED, and Sterylab
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launches, government initiatives, technological upgradation, market expansion, and marketing tactics
  • The global sarcoma biopsy market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for Surgical Cushions Market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:

  • Global Sarcoma Biopsy Market, By Product Type:
    • Reusable Devices
    • Disposable Devices
  • Global Sarcoma Biopsy Market, By End User:
    • Hospitals
    • Ambulatory Surgical Centers
    • Diagnostic Centers
  • Global Sarcoma Biopsy Market, By Region:
    • North America
      • By Country:
        • U.S.
        • Canada
      • By Product Type:
        • Reusable Devices
        • Disposable Devices
      • By End User:
        • Hospitals
        • Ambulatory Surgical Centers
        • Diagnostic Centers
    • Europe
      • By Country:
        • U.K.
        • Germany
        • Italy
        • Spain
        • France
        • Russia
        • Rest of Europe
      • By Product Type:
        • Reusable Devices
        • Disposable Devices
      • By End User:
        • Hospitals
        • Ambulatory Surgical Centers
        • Diagnostic Centers
    • Asia Pacific
      • By Country:
        • Australia
        • India
        • China
        • Japan
        • ASEAN
        • South Korea
        • Rest of Asia Pacific
      • By Product Type:
        • Reusable Devices
        • Disposable Devices
      • By End User:
        • Hospitals
        • Ambulatory Surgical Centers
        • Diagnostic Centers
    • Latin America
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
      • By Product Type:
        • Reusable Devices
        • Disposable Devices
      • By End User:
        • Hospitals
        • Ambulatory Surgical Centers
        • Diagnostic Centers
    • Middle East
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
      • By Product Type:
        • Reusable Devices
        • Disposable Devices
      • By End User:
        • Hospitals
        • Ambulatory Surgical Centers
        • Diagnostic Centers
    • Africa
      • By Country/Region:
        • South Africa
        • Central Africa
        • North Africa
      • By Product Type:
        • Reusable Devices
        • Disposable Devices
      • By End User:
        • Hospitals
        • Ambulatory Surgical Centers
        • Diagnostic Centers
  • Company Profiles
    • R. Bard, Inc.*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • Becton, Dickinson and Company
    • Argon Medical Devices
    • InVivo Therapeutics Corporation
    • Cook Medical Incorporated
    • UROMED
    • Sterylab

 “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Overview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippet, By End User
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Market Opportunities
    • Impact Analysis
    • Market Trends
    • Key Developments
    • PEST Analysis
    • Porter’s Five Forces model
  4. Global Sarcoma Biopsy Market, By Product Type, 2016 – 2027, (US$ Million)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Reusable Devices
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Disposable Devices
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
  5. Global Sarcoma Biopsy Market, By End User, 2016 – 2027, (US$ Million)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Hospitals  
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Ambulatory Surgical Centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Diagnostic Centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
  6. Global Sarcoma Biopsy Market, By Region, 2016 – 2027, (US$ Million)
    • Introduction
      • Market Share Analysis, By Region, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, By Region, 2017 – 2027
      • Regional Trends
    • North America
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
        • China
        • Japan
        • India
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Africa
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Country/Region, 2016 – 2027, (US$ Million)
        • North Africa
        • Central Africa
        • South Africa
    • Middle East
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
        • GCC
        • Israel
        • Rest of Middle East
  7. Competitive Landscape
    • Company Profiles
      • C. R. Bard, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Becton, Dickinson and Company
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Argon Medical Devices
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • InVivo Therapeutics Corporation
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Cook Medical Incorporated
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • UROMED
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Sterylab
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
  8. Section
    • References
    • Research Methodology
    • About Us and Sales Contact

*Browse 26 market data tables and 25 figures on "Global Sarcoma Biopsy Market” - Forecast to 2027”

Frequently Asked Questions

The CAGR of the global sarcoma biopsy market is expected to be 2.8% during the forecast period (2020-2027).
The value of global market for global sarcoma biopsy market was US$ 192.55 million in 2019.
The prominent players of global sarcoma biopsy market across the globe include C. R. Bard, Inc., Becton, Dickinson and Company, Argon Medical Devices, InVivo Therapeutics Corporation, Cook Medical Incorporated, UROMED, and Sterylab
The global sarcoma biopsy market is expected to reach US $ 247.47 million by 2027.
North America is major region for global sarcoma biopsy market.
Increasing prevalence of bone cancer, increasing prevalence of osteosarcoma and technology advancement in the field of biopsy
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner